T. Rowe Price Associates’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,198
| Closed | -$35K | – | 3066 |
|
|
2025
Q1 | $35K | Hold |
51,198
| – | – | ﹤0.01% | 2965 |
|
|
2024
Q4 | $49K | Buy |
51,198
+10,428
| +26% | +$9.98K | ﹤0.01% | 2934 |
|
|
2024
Q3 | $62K | Hold |
40,770
| – | – | ﹤0.01% | 2901 |
|
|
2024
Q2 | $0 | Buy |
+40,770
| New | – | ﹤0.01% | 2931 |
|
|
2022
Q4 | – | Sell |
-34,400
| Closed | -$29K | – | 2936 |
|
|
2022
Q3 | $29K | Hold |
34,400
| – | – | ﹤0.01% | 2887 |
|
|
2022
Q2 | $37K | Sell |
34,400
-10,244
| -23% | -$11K | ﹤0.01% | 2886 |
|
|
2022
Q1 | $56K | Buy |
44,644
+19,800
| +80% | +$24.8K | ﹤0.01% | 2905 |
|
|
2021
Q4 | $40K | Sell |
24,844
-2,700
| -10% | -$4.35K | ﹤0.01% | 2931 |
|
|
2021
Q3 | $90K | Buy |
27,544
+2,700
| +11% | +$8.82K | ﹤0.01% | 2854 |
|
|
2021
Q2 | $157K | Buy |
+24,844
| New | +$157K | ﹤0.01% | 2765 |
|